HIMSJuly 29, 2026 at 4:34 PM UTCHealth Care Equipment & Services

FTC Lawsuit Piles Privacy and Trust Risks onto Hims & Hers' Already Pressured Turnaround

Read source article

What happened

The U.S. FTC is suing Hims & Hers for allegedly sharing users' sensitive health data with Meta and Snap and for deceptive billing practices, directly attacking the company's privacy promises and customer trust. This legal action compounds the platform's existing challenges, as it already faces a difficult pivot from high-margin compounded GLP-1s to lower-margin branded obesity treatments, with recent Q1 2026 results showing slowing growth and margin compression. The trust erosion from the FTC suit could further pressure customer acquisition and retention, potentially weakening the subscription economics that underpin the platform's moat. The stock's rich valuation at 50x EV/EBITDA leaves little room for operational missteps, and this regulatory blow increases the probability that the bear case scenario—where revenue growth stays below 10% and gross margins remain weak—materializes. With the branded obesity transition yet to prove its earnings power and now this new regulatory overhang, the burden of proof falls squarely on management to demonstrate that growth quality can recover, making the stock a risky hold at current levels.

Implication

For investors, the FTC action directly threatens Hims & Hers' brand reputation and customer trust, which are core to its subscription model. The alleged privacy breaches and deceptive billing practices could lead to financial penalties, mandated changes in data handling and marketing, and increased churn, all of which would pressure the already challenged economics. This comes at a precarious time as the company attempts to stabilize growth and margins following its strategic shift away from compounded GLP-1s. The lawsuit's outcome and any resulting operational restrictions will be critical to monitor in coming quarters; a worst-case scenario could accelerate the bear case to below $24 per share. As a result, the margin of safety has narrowed further, and the stock likely needs a lower entry point to account for these elevated risks.

Thesis delta

The FTC lawsuit introduces a new, concrete privacy and consumer protection risk that was not fully priced into the existing thesis. While the prior analysis flagged regulatory headwinds, this action directly erodes the trust foundation of the platform and could accelerate subscriber erosion and margin pressure. Consequently, the probability of the bear case has increased, and the timeline for any recovery has likely been extended.

Confidence

high